Browse > Article
http://dx.doi.org/10.22722/KJPM.2020.28.1.53

Childhood Trauma and Pharmacotherapy Retention among Outpatients with Panic Disorder  

Kim, Dong Joo (Department of Psychiatry, Hanyang University College of Medicine)
Kim, Daeho (Department of Psychiatry, Hanyang University College of Medicine)
Lee, Jinbok (Department of Psychiatry, Hanyang University College of Medicine)
Kim, Yaeseul (Department of Psychiatry, Hanyang University College of Medicine)
Sohn, Sujin (Department of Psychiatry, Hanyang University College of Medicine)
Publication Information
Korean Journal of Psychosomatic Medicine / v.28, no.1, 2020 , pp. 53-62 More about this Journal
Abstract
Objectives : This study investigated lifetime experiences of trauma, treatment retention, and psychiatric symptoms among outpatients with panic disorder after initiation of pharmacotherapy. Our research hypothesis was that panic patients with childhood trauma would display more severe symptoms and less treatment retention compared to those without such history. Methods : A total of 135 first-visit outpatients with DSM-IV panic disorder were approached during the period from March 2012 to August 2016. Fifty-three patients (39%) either refused or returned incomplete questionnaires, leading to a final sample size of 82. Participants completed the Trauma History Screen, the Beck Depression Inventory, the Beck Anxiety Inventory, and the Abbreviated PTSD checklist. Results : The number of lifetime trauma was significantly correlated with treatment retention (rho=-0.269, p=0.015). Among subtypes of trauma, only childhood physical abuse was significantly correlated with treatment retention (rho=-0.298, p=0.007). Conclusions : Our results indicated that psychological trauma, particularly of an interpersonal nature from childhood, can affect pharmacotherapy treatment retention in panic disorder. This may be mediated by poor patient-doctor relationships originating from trust issues among childhood trauma survivors or lack of perceived improvement due to the more severe symptoms and unfavorable course experienced by those with childhood trauma. Further studies are needed to explore the reasons for poor treatment adherence in this population.
Keywords
Panic disorder; Childhood trauma; Pharmacotherapy; Medication adherence; Patient compliance;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S, Huang B, Saha TD. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67:363-374.   DOI
2 Cho MJ, Seong SJ, Park JE, Chung IW, Lee YM, Bae A, Ahn JH, Lee DW, Bae JN, Cho SJ, Park JI, Son J, Chang SM, Hahm BJ, Lee JY, Sohn JH, Kim JS, Hong JP. Prevalence and correlates of DSM-IV mental disorders in South Korean Adults: the Korean Epidemiologic Catchment Area Study 2011. Psychiatry Investig 2015;12:164-170.   DOI
3 Health Insurance Review and Assessment Service. Statistics of Diseases, 2010-2016. Seoul: Health Insurance Review and Assessment Service;2017.
4 Katon W. Panic disorder: epidemiology, diagnosis, and treatment in primary care. J Clin Psychiatry 1986;47 Suppl:21-30.
5 Zaubler TS, Katon W. Panic disorder in the general medical setting. J Psychosom Res 1998;44:25-42.   DOI
6 Brown GW, Harris TO. Aetiology of anxiety and depressive disorders in an inner-city population. 1. Early adversity. Psychol Med 1993;23:143-154.   DOI
7 Safren SA, Gershuny BS, Marzol P, Otto MW, Pollack MH. History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. J Nerv Ment Dis 2002;190:453-456.   DOI
8 Cougle JR, Timpano KR, Sachs-Ericsson N, Keough ME, Riccardi CJ. Examining t he u nique relationships b etween anxiety disorders and childhood physical and sexual abuse in the National Comorbidity Survey-Replication. Psychiatry Res 2010;177:150-155.   DOI
9 Goodwin RD, Fergusson DM, Horwood LJ. Childhood abuse and familial violence and the risk of panic attacks and panic disorder in young adulthood. Psychol Med 2005;35:881-890.   DOI
10 De Venter M, Van Den Eede F, Pattyn T, Wouters K, Veltman DJ, Penninx B, Sabbe B. Impact of childhood trauma on course of panic disorder: contribution of clinical and personality characteristics. Acta Psychiatr Scand 2017;135:554-563.   DOI
11 Marchesi C, Cantoni A, Fonto S, Giannelli MR, Maggini C. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study. Pharmacopsychiatry 2006;39:60-65.   DOI
12 Nay W, Brown R, Roberson-Nay R. Longitudinal course of panic disorder with and without agoraphobia using the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychiatry Res 2013;208:54-61.   DOI
13 Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005;88:27-45.   DOI
14 Roy-Byrne PP, Cowley DS. Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety 1994;1:151-160.   DOI
15 Batelaan NM, de Graaf R, Penninx BW, van Balkom AJ, Vollebergh WA, Beekman AT. The 2-year prognosis of panic episodes in the general population. Psychol Med 2010;40:147-157.   DOI
16 Imai H, Tajika A, Chen P, Pompoli A, Furukawa TA. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. Cochrane Database Syst Rev 2016;10:CD011170.
17 Mukherjee S, Sullivan G, Perry D, Verdugo B, Means-Christensen A, Schraufnagel T, Sherbourne CD, Stein MB, Craske MG, Roy-Byrne PP. Adherence to treatment among economically disadvantaged patients with panic disorder. Psychiatr Serv 2006;57:1745-1750.   DOI
18 Marchesi C. Pharmacological management of panic disorder. Neuropsychiatr Dis Treat 2008;4:93-106.   DOI
19 Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet 2006;368:1023-1032.   DOI
20 Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry 2001;158:1989-1992.   DOI
21 Perna G, Alciati A, Riva A, Micieli W, Caldirola D. Longterm pharmacological treatments of anxiety disorders: an updated systematic review. Curr Psychiatry Rep 2016;18:23.   DOI
22 Carlson EB, Smith SR, Palmieri PA, Dalenberg C, Ruzek JI, Kimerling R, Burling TA, Spain DA. Development and validation of a brief self-report measure of trauma exposure: the Trauma History Screen. Psychol Assess 2011;23:463-477.   DOI
23 Baeza-Velasco C, Olie E, Beziat S, Guillaume S, Courtet P. Determinants of suboptimal medication adherence in patients with a major depressive episode. Depress Anxiety 2019;36:244-251.   DOI
24 Kim C, Jeong Y, Kim EK, Park SC, Jo HY, Kim D. Childhood trauma and treatment Implications in major depressive disorder in South Korea: comparison with medical outpatients and two-year follow-up. Mood Emot 2019;17.
25 Lee K, Kim D, Cho Y. Exploratory Factor Analysis of the Beck Anxiety Inventory and the Beck Depression Inventory-II in a Psychiatric Outpatient Population. J Korean Med Sci 2018;33:e128.   DOI
26 Kim K, Kim J, Won H. Korean manual of symptom checklist-90-revision. Seoul: Jung Ang Juk Sung Publisher 1984:8-10.
27 Beck AT, Steer RA, Brown G. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
28 Sung HM, Kim JB, Park YN, Bai DS, Lee SH, Ahn HN. A study on the reliability and the validity of Korean version of the Beck Depression Inventory-II (BDI-II). J Korean Soc Biol Ther Psychiatry 2008;14.
29 Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-897.   DOI
30 Yook S, Kim Z. A clinical study on the Korean version of Beck Anxiety Inventory: comparative study of patient and non-patient. Korean J Clin Psychol 1997;16:185-197.
31 Teicher MH, Samson JA. Childhood maltreatment and psychopathology: a case for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am J Psychiatry 2013;170:1114-1133.   DOI
32 Liu Y, Sareen J, Bolton J, Wang J. Development and validation of a risk-prediction algorithm for the recurrence of panic disorder. Depress Anxiety 2015;32:341-348.   DOI
33 Cowley DS, Ha EH, Roy-Byrne PP. Determinants of pharmacologic treatment failure in panic disorder. J Clin Psychiatry 1997;58:555-561;quiz 562-553.   DOI
34 Yonkers KA, Ellison JM, Shera DM, Pratt LA, Cole JO, Fierman E, Keller MB, Lavori PW. Description of antipanic therapy in a prospective longitudinal study. J Clin Psychopharmacol 1996;16:223-232.   DOI
35 Derogatis LR, Rickels K, Rock AF. T he SCL-90 a nd the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976;128:280-289.   DOI
36 Edwards VJ, Holden GW, Felitti VJ, Anda RF. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am J Psychiatry 2003;160:1453-1460.   DOI
37 Bandelow B, Spath C, Tichauer GA, Broocks A, Hajak G, Ruther E. Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder. Compr Psychiatry 2002;43:269-278.   DOI
38 Grilo CM, Money R, Barlow DH, Goddard AW, Gorman JM, Hofmann SG, Papp LA, Shear MK, Woods SW. Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry 1998;39:323-332.   DOI
39 Miniati M, Rucci P, Benvenuti A, Frank E, Buttenfield J, Giorgi G, Cassano GB. Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse. J Psychiatr Res 2010;44:302-309.   DOI
40 White KS, Allen LB, Barlow DH, Gorman JM, Shear MK, Woods SW. Attrition in a multicenter clinical trial for panic disorder. J Nerv Ment Dis 2010;198:665-671.   DOI
41 Hung CI. Factors predicting adherence to antidepressant treatment. Curr Opin Psychiatry 2014;27:344-349.   DOI
42 Lecomte T, Spidel A, Leclerc C, MacEwan GW, Greaves C, Bentall RP. Predictors and profiles of t reatment non-adherence and engagement in services problems in early psychosis. Schizophr Res 2008;102:295-302.   DOI
43 Carter JC, Bewell C, Blackmore E, Woodside DB. The impact of childhood sexual abuse in anorexia nervosa. Child Abuse Negl 2006;30:257-269.   DOI
44 Keller SM, Zoellner LA, Feeny NC. Understanding factors associated with early therapeutic alliance in PTSD treatment: adherence, childhood sexual abuse history, and social support. J Consult Clin Psychol 2010;78:974-979.   DOI
45 Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSMIV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627.   DOI